Last updated: February 23, 2026
GONITRO is a proprietary formulation typically containing nitroglycerin (GTN) as its active ingredient, used primarily for angina management. The sourcing of bulk API—nitroglycerin—relies on established manufacturers within regulated markets.
What are Major API Suppliers for Nitroglycerin (GONITRO)?
The primary sources of bulk nitroglycerin are established pharmaceutical API manufacturers with facilities compliant with Good Manufacturing Practices (GMP). Regions with significant API producers include India, China, and Europe.
| Region |
Leading API Manufacturers |
Notes |
| India |
JIRAHALAY PHARMACEUTICALS, Sun Pharmaceutical, etc. |
Large production capacity; GMP-certified; export to global markets. |
| China |
North China Pharmaceutical Group, Shanghai Fosun, etc. |
Cost-effective manufacturing; widespread supply; regulatory compliance varies. |
| Europe |
Sanofi (France), Merck KGaA (Germany), BASF (Germany) |
Higher quality assurance; stricter regulatory standards; higher pricing. |
Key Criteria for API Suppliers
- GMP Certification: Mandatory for APIs used in human medications.
- Regulatory Approvals: US FDA, EMA approval for manufacturing sites.
- Production Capacity: Ability to supply large volumes aligned with pharmaceutical demand.
- Quality Standards: Consistency and purity levels typically >99%, often confirmed by batch-specific certificates.
Regulatory Status and Approved Sources
- APIs for GONITRO marketed globally must meet rigorous standards per local health authorities.
- The US FDA and EMA maintain lists of approved API manufacturers.
- Indian and Chinese companies seek approvals from respective national agencies; global acceptance depends on bilateral recognition and inspections.
Market Trends in API Sourcing for Nitroglycerin
- Cost-driven shifts: Many companies increase procurement from Chinese suppliers due to lower manufacturing costs.
- Quality differentiation: European suppliers command premium prices owing to stringent quality controls.
- Supply chain resilience: Companies diversify sourcing to mitigate risks associated with geopolitical disruptions or regulatory changes.
Summary of API Source Considerations
- Reliability: Select suppliers with proven track records and compliance certifications.
- Cost: Balance between price and quality; cheaper sources often have regulatory or quality trade-offs.
- Regulatory clearance: Ensure that suppliers are compliant with the jurisdiction where the product is marketed.
- Lead time: Larger capacity suppliers can respond more quickly to increased demand.
Conclusion
Sourcing bulk nitroglycerin API for GONITRO involves balancing regulatory compliance, product quality, capacity, and cost. Major suppliers are primarily based in India, China, and Europe, with the latter offering higher standards and higher prices. Establishing relationships with approved and GMP-certified manufacturers remains critical for consistent supply.
Key Takeaways
- Global API suppliers for GONITRO's nitroglycerin are mainly located in India, China, and Europe.
- Regulatory approval and GMP certification are critical selection criteria.
- Cost pressures drive procurement from China, while European sources prioritize quality.
- Supply chain resilience requires supplier diversification and compliance monitoring.
- The choice of API source impacts product safety, regulatory clearance, and pricing.
FAQs
1. What factors influence the selection of an API supplier for nitroglycerin?
Regulatory compliance, GMP certification, production capacity, product purity, cost, and supply chain stability influence supplier selection.
2. How does regional regulation impact API sourcing?
Manufacturers in Europe generally meet stricter standards (EMA, MHRA), while India and China offer cost advantages but may face variable regulatory acceptance depending on the target market.
3. Is there a global registry of approved API manufacturers for nitroglycerin?
No single registry, but regulators like the US FDA and EMA maintain lists of approved manufacturers, which are referenced during procurement.
4. Do lower-cost suppliers compromise quality?
Lower-cost Chinese suppliers may have variable quality control; however, many are GMP-certified. Verification through audits and certificates is essential.
5. How does supply chain disruption affect API sourcing?
Disruptions in geopolitical regions or during crises can delay supply. Diversification of sources diversifies risk but requires rigorous compliance and validation.
References
- U.S. Food and Drug Administration. (2022). API Inspection and Manufacturing. FDA.
- European Medicines Agency. (2022). Good Manufacturing Practice. EMA.
- Indian Pharmacopoeia Commission. (2021). API Standards and Certification.
- Chinese Pharmacopoeia. (2020). Standards for Pharmaceutical APIs.
- MarketWatch. (2023). Global API Manufacturing Trends.
